# TAS2R20

## Overview
TAS2R20 is a gene that encodes the taste 2 receptor member 20, a protein belonging to the family of G protein-coupled receptors (GPCRs) specifically involved in the perception of bitter taste. These receptors are characterized by their seven transmembrane helices, which are integral to their function in detecting bitter compounds. The TAS2R20 protein is primarily expressed in taste receptor cells on the tongue, where it plays a crucial role in dietary choices by triggering intracellular signaling pathways upon activation by bitter substances, such as vanillin (Ahmad2020G; Morini2021Vanillin). Beyond its role in taste perception, TAS2R20 has been implicated in various physiological and pathological processes, including cardiovascular diseases and cancer, where its expression levels and genetic variations may influence disease progression and patient outcomes (Bi2024Comprehensive; Chazara2023Assessing).

## Structure
The TAS2R20 protein is a member of the taste receptor 2 (TAS2R) family, which are G protein-coupled receptors (GPCRs) involved in bitter taste perception. These receptors typically feature seven transmembrane helices, a hallmark of GPCRs, which contribute to their secondary structure (Ahmad2020G). The primary structure of TAS2R20 includes specific amino acid residues crucial for its function, such as W88 and Q265, located in the transmembrane domains TMD3 and TMD7. These residues are essential for binding bacterial acyl homoserine lactones (AHLs) (Ahmad2020G).

The tertiary structure of TAS2R20 involves the folding of these transmembrane helices to form a deep agonist binding cavity, which is typical of TAS2Rs. This structure allows the receptor to bind a wide range of agonists with low apparent affinity (Ahmad2020G). The receptor's activation is facilitated by hydrophobic amino acids within the transmembrane domains, a common feature in GPCRs (Ahmad2020G).

Post-translational modifications, such as N-glycosylation, play a significant role in the receptor's trafficking and function, with specific sites on the N-terminus being important for proper localization (Tan2022Construction). The molecular structure of TAS2R20 does not typically involve quaternary structures, as is common with GPCRs.

## Function
TAS2R20 is a member of the TAS2R family of G protein-coupled receptors, which are primarily involved in the perception of bitter taste. These receptors are located on the surface of taste receptor cells in the tongue, where they detect specific bitter compounds. Upon activation by bitter substances, TAS2R20 triggers intracellular signaling pathways that lead to the mobilization of calcium ions, resulting in the perception of bitterness. This process is crucial for dietary choices and the avoidance of potentially harmful substances (Morini2021Vanillin).

In a study by Morini et al., TAS2R20 was shown to be activated by vanillin, a compound known for its bitter taste, in a concentration-dependent manner. The study used HEK293 cells engineered to express TAS2R20, among other receptors, to demonstrate this activation through calcium mobilization assays. The EC50 value for TAS2R20 activation by vanillin was determined to be 0.53 Â± 0.09 mM, indicating its role in mediating the bitterness of vanillin (Morini2021Vanillin).

While the primary function of TAS2R20 is related to taste perception, the study did not address its function in other physiological processes or its role in healthy human cells beyond taste (Morini2021Vanillin).

## Clinical Significance
TAS2R20 has been implicated in several diseases and conditions through alterations in its expression levels and genetic mutations. In heart failure, TAS2R20 is associated with an increased risk of cardiovascular death. The gene's expression is significantly elevated in the myocardium of patients with heart failure with preserved ejection fraction (HFpEF), suggesting a potential role in the progression of this condition (Chazara2023Assessing). 

In the context of cancer, TAS2R20 expression is elevated in colon cancer tissues compared to normal tissues, indicating a possible role in cancer development. High expression levels of TAS2R20 are associated with poorer survival outcomes in colon cancer patients, suggesting its potential as a prognostic marker (Bi2024Comprehensive). Additionally, TAS2R20 has been linked to negative survival outcomes in esophageal and prostate adenocarcinomas, highlighting its potential prognostic significance in these cancers as well (Carey2022Impact).

Overall, TAS2R20's altered expression and genetic variations are associated with significant clinical outcomes in heart failure and various cancers, indicating its potential as a target for therapeutic interventions and prognostic assessments.


## References


[1. (Bi2024Comprehensive) Suzhen Bi, Jie Zhu, Liting Huang, Wanting Feng, Lulu Peng, Liangqi Leng, Yin Wang, Peipei Shan, Weikaixin Kong, and Sujie Zhu. Comprehensive analysis of the function and prognostic value of tas2rs family-related genes in colon cancer. International Journal of Molecular Sciences, 25(13):6849, June 2024. URL: http://dx.doi.org/10.3390/ijms25136849, doi:10.3390/ijms25136849. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms25136849)

[2. (Ahmad2020G) Raise Ahmad and Julie E. Dalziel. G protein-coupled receptors in taste physiology and pharmacology. Frontiers in Pharmacology, November 2020. URL: http://dx.doi.org/10.3389/fphar.2020.587664, doi:10.3389/fphar.2020.587664. This article has 139 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2020.587664)

[3. (Tan2022Construction) Shi Min Tan and Wei-Guang Seetoh. Construction of a bioluminescence-based assay for bitter taste receptors (tas2rs). Scientific Reports, October 2022. URL: http://dx.doi.org/10.1038/s41598-022-21678-3, doi:10.1038/s41598-022-21678-3. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-022-21678-3)

4. (Chazara2023Assessing) Assessing the role of rare pathogenic variants in heart failure progression by exome sequencing in 8,089 patients. This article has 0 citations.

[5. (Carey2022Impact) Ryan M. Carey, TaeBeom Kim, Noam A. Cohen, Robert J. Lee, and Kevin T. Nead. Impact of sweet, umami, and bitter taste receptor (tas1r and tas2r) genomic and expression alterations in solid tumors on survival. Scientific Reports, May 2022. URL: http://dx.doi.org/10.1038/s41598-022-12788-z, doi:10.1038/s41598-022-12788-z. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-022-12788-z)

[6. (Morini2021Vanillin) Gabriella Morini, Marcel Winnig, Timo Vennegeerts, Gigliola Borgonovo, and Angela Bassoli. Vanillin activates human bitter taste receptors tas2r14, tas2r20, and tas2r39. Frontiers in Nutrition, July 2021. URL: http://dx.doi.org/10.3389/fnut.2021.683627, doi:10.3389/fnut.2021.683627. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fnut.2021.683627)